Related Experiment Video
Updated: Feb 13, 2026

Introduction to the Ultrasound Targeted Microbubble Destruction Technique
Published on: June 12, 2011
Ultrasound Molecular Imaging of Atherosclerosis for Early Diagnosis and Therapeutic Evaluation through Leucocyte-like
Fei Yan1, Yu Sun2,3, Yang Mao4
1Paul C. Lauterbur Research Center for Biomedical Imaging, Institute of Biomedical and Health Engineering, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055 China.
Insights
Researchers developed targeted microbubbles (MBs) to improve ultrasound imaging of atherosclerosis. These MBs effectively adhere to inflammatory cells, enhancing early diagnosis and monitoring of treatment efficacy for cardiovascular disease.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Medical Imaging
Background:
- Atherosclerosis, a cardiovascular disease driven by inflammation and lipid accumulation, poses a significant health risk.
- Early diagnosis and therapeutic monitoring of atherosclerosis are crucial for patient outcomes.
- Targeted contrast-enhanced ultrasonography shows promise for noninvasive atherosclerosis evaluation, but microbubble adhesion in arteries is challenging.
Purpose of the Study:
- To develop an improved targeted microbubble (MB) for enhanced ultrasound imaging of atherosclerosis.
- To mimic leukocyte adhesion mechanisms for superior cell targeting in vascular imaging.
- To evaluate the diagnostic and therapeutic monitoring potential of the novel MBs.
Main Methods:
- Developed VCAM-1/ICAM-1/P-selectin-targeted MBs (MB_VIS) by integrating antibodies and sialyl Lewis X (sLe^x) onto the MB surface.
- Tested MB_VIS affinity to inflammatory cells under static and dynamic flow conditions.
- Assessed ultrasound imaging signal enhancement and therapeutic response in atorvastatin-treated ApoE-deficient mice.
Main Results:
- MB_VIS demonstrated high affinity to inflammatory cells.
- MB_VIS achieved significantly enhanced ultrasound imaging signals compared to single- or dual-targeted MBs.
- Ultrasound signals decreased in atorvastatin-treated mice, indicating therapeutic efficacy, confirmed by histology.
Conclusions:
- The developed MB_VIS probe offers a promising solution for microbubble adhesion challenges in vascular imaging.
- MB_VIS enables enhanced ultrasound molecular imaging for early-stage atherosclerosis detection.
- This technology facilitates effective therapeutic evaluation of atherosclerosis treatments.
Abstract:
Cardiovascular diseases resulting from atherosclerosis have become a serious threat to human health. It is well-known that an ongoing inflammatory response is involved during atherosclerosis progression that ultimately results in the accumulation of lipids and formation of plaques. Monitoring the pathological changes during the inflammatory response will be of great significance for early diagnosis and therapeutic evaluation of atherosclerosis. Targeted contrast-enhanced ultrasonography has been shown to be a promising noninvasive imaging technique for evaluating the degree of atherosclerosis and may potentially be translated to clinical imaging in the future. However, inadequate cell adhesion of targeted microbubbles (MBs) in large arterial vessels still remains a great challenge. Methods: By mimicking the leucocytes that are recruited to the vessel wall during the initiation of atherosclerosis through selectin-dependent arrest and cell adhesion molecule-mediated firm cell adhesion, we developed VCAM-1/ICAM-1/P-selectin-targeted MBVIS by integrating VCAM-1 and ICAM-1 antibodies and synthetic polymeric sialyl Lewis X (sLex) onto the MB surface. Results: The resulting MBVIS had a high affinity to inflammatory bEnd.3 cells in both static and dynamic flow conditions. Significantly enhanced ultrasound imaging signals were achieved by MBVIS in detecting the atherosclerosis progress when compared with the single- or dual-targeted MBs. Taking advantage of the artificial MBVIS, less ultrasound imaging signals were found in the atorvastatin-treated, but not placebo-treated, ApoE-deficient mice with atherosclerosis, revealing a potential therapeutic efficacy of atorvastatin for early stage atherosclerosis. This was further confirmed by histologic staining examination. Conclusions: Our study provides a promising ultrasound molecular imaging probe for early-stage diagnosis and therapeutic evaluation of atherosclerosis.
More Related Videos
09:43In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
Published on: August 4, 2011
08:08Evaluating Targeting Accuracy in the Focal Plane for an Ultrasound-guided High-intensity Focused Ultrasound Phased-array System
Published on: March 6, 2019
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Multiple Allele Traits
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Atherosclerosis IV: Nursing Management